The civic body has claimed that a pilot study combining two antibody drugs, casirivimab and imdevimab, has been successful in treating over 200 Covid-19 patients with mild to moderate symptoms at SevenHills Hospital. Only one patient required oxygen supply after the combined medication and the mortality rate reduced by 70 per cent.

The hospitalisation period reduced to five-six days from 13-14. Doctors claimed that the drug combination will reduce side effects by avoiding the use of other drugs like remdesivir, steroids, etc.